Defects in Wiskott-Aldrich syndrome blood cells

Blood

Volumn 87, Issue 7, 1996, Pages 2621-2631

  Remold O'Donnell, Eileen ^a,b   Rosen, Fred S ^a   Kenney, Dianne M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOSIALIN; MESSENGER RNA;

BETA THALASSEMIA; CHROMOSOME XP; CLINICAL FEATURE; DUCHENNE MUSCULAR DYSTROPHY; ECZEMA; GENE MAPPING; GENE MUTATION; HEREDITARY ELLIPTOCYTOSIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; INFANT; MAJOR CLINICAL STUDY; MALE; MICROVILLUS; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; T LYMPHOCYTE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; WISKOTT ALDRICH SYNDROME; X CHROMOSOME RECESSIVE DISORDER;

EID: 0029988146     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.7.2621.bloodjournal8772621     Document Type: Review

References (119)

1. Wiskott A: Familiärer, angeborener morbus Werlhofii. Monatschrift Kinderheil 68:212, 1936
2. Aldrich RA, Steinberg AG, Campbell DC: Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13:133, 1954
3. Derry JMJ, Ochs HD, Francke U: Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78:635, 1994
4. Fischer A: Primary T-cell immunodeficiencies. Curr Opin Immunol 5:569, 1993
5. Rosen FS, Cooper MD, Wedgwood RJP: The primary immunodeficiencies. N Engl J Med 333:431, 1995
6. Kenney DM: Wiskott-Aldrich syndrome and related X-linked thrombocytopenia. Curr Opin Pediatr 2:931, 1990
7. Gröttum KA, Hovig T, Holmsen H, Abrahamsen AF, Jeremic M, Seip M. Wiskott-Aldrich syndrome: Qualitative platelet defects and short platelet survival. Br J Haematol 17:373, 1969
8. Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, Strina D, Patrosso MC, Ramenghi U, Sacco MG, Ugazio A, Vezzoni P: X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nature Genet 9:414, 1995
9. Murphy S, Oski FA, Naiman J, Lusch CJ, Goldberg S, Gardner FH: Platelet size and kinetics in hereditary and acquired thrombocytopenia. N Engl J Med 286:499, 1972
10. Lum LG, Tubergen DG, Corash L, Blaese RM: Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome. N Engl J Med 302:892, 1980
11. Corash L, Shafer B, Blaese RM: Platelet-associated immunoglobulin, platelet size, and the effect of spleneclomy in the Wiskott-Aldrich syndrome. Blood 65:1439, 1985
12. Baldini MG: Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann NY Acad Sci 201:437, 1972
13. Marone G, Albini F, Di Martino L, Quattrin S, Poto S, Condorelli M: The Wiskott-Aldrich syndrome: Studies of platelets, basophils and polymorphonuclear leucocytes. Br J Haematol 62:737, 1986
14. Verhoeven AJM, van Oostrum IEA, van Haarlem H, Akkerman J-WN: Impaired energy metabolism in platelets from patients with Wiskott-Aldrich syndrome. Thromb Haemost 61:10, 1989
15. Stormorken H, Helium B, Egeland T, Abrahamsen TG, Hovig T: X-linked thrombocytopenia and thrombocytopathia attenuated Wiskott-Aldrich syndrome. Thromb Haemost 65:300, 1991
16. Cooper, MD, Chase HP, Lowman JT, Krivit W, Good RA: Wiskott-Aldrich syndrome: An immunologic deficiency disease involving the afferent limb of immunity. Am J Med 44:499, 1968
17. Blaese RM, Strober W, Brown RS, Waldmann TA: The Wiskott-Aldrich syndrome: A disorder with a possible defect in antigen processing or recognition. Lancet 1:1056, 1968
18. Oppenheim JJ, Blaese RM, Waldmann TA: Defective lymphocyte transformation and delayed hypersensitivity in Wiskott-Aldrich syndrome. J Immunol 104:835, 1970
19. Ammann AJ, Hong R: Disorders of the T cell system, in Stiehm ER, Fulginiti VA (eds): Immunological Disorders in Infants and Children. Philadelphia, PA, Saunders, 1980, p 286
20. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ: The Wiskott-Aldrich syndrome: Studies of lymphocytes, granulocytes and platelets. Blood 55:243, 1980
21. Perry GS, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, Hanson MR, Fahlstrom SM, Krivit W, Kersey JH: The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). J Pediatr 97:72, 1980
22. Cotelingam JD, Witebsky FG, Hsu SM, Blaese RM, Jaffe ES: Malignant lymphoma in patients with the Wiskott-Aldrich Syndrome. Cancer Invest 3:515, 1985
23. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA: A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876, 1994
24. Parkman R, Rappeport J, Geha RS, Belli J, Cassady R, Levey R, Nathan DG, Rosen FS: Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med 298:921, 1978
25. Kapoor N, Kirkpatrick D, Blaese RM, Oleske J, Hilgartner MH, Chaganti RSK, Good RA, O'Reilly RJ: Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. Blood 57:692, 1981
26. Rumelhard SL, Trigg M, Horowitz SD, Hong R: Monoclonal antibody T cell depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome. Blood 75:1031, 1990
27. Mullen CA, Anderson KD, Blaese RM: Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich Syndrome: Long-term follow-up of 62 cases. Blood 82:2961, 1993
28. Krivit W, Good RA: Aldrich's syndrome (thrombocytopenia. eczema and infection in infants). Am J Dis Child 97:137, 1959
29. Ayoub EM, Dudding BA, Cooper MD: Dichotomy of antibody response to group A streptococcal antigens in Wiskott-Aldrich syndrome. J Lab Clin Med 72:971, 1968
30. Greer WL, Higgins E, Sutherland DR, Novogrodsky A, Brockhausen I, Peacocke M, Rubin LA, Baker M, Dennis JW, Siminovitch KA: Altered expression of leukocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. Biochem Cell Biol 67:503, 1989
31. Siminovitch KA, Greer WL, Axelsson B, Rubin LA, Novogrodsky A, Peacocke M: Selective impairment of CD43-mediated T cell activation in the Wiskott-Aldrich syndrome. Immunodeficiency 4:99, 1993
32. Siminovitch KA, Greer WL, Novogrodsky A, Axelsson B, Somani A-K, Peacocke M: A diagnostic assay for the Wiskott-Aldrich syndrome and its variant forms. J Invest Med 43:159, 1995
33. West CD, Hong R, and Holland NH: Immunoglobulin levels from the newborn period to adulthood and in immunodeficiency states. J Clin Invest 41:2054, 1962
34. Blaese RM, Strober W, Levy AL, Waldmann TA: Hypercatabolism of IgG, IgA, IgM and albumin in the Wiskott-Aldrich syndrome. J Clin Invest 50:2331, 1971
35. Perez-Atayde AR, Rosen FS: Pathology of the primary immunodeficiency diseases, in Colvin RB, Bhan AK, McCluskey RT (eds): Diagnostic Immunopathology (ed 2). New York, NY, Raven 1995
36. Altman LC, Snyderman R, Blaese RM: Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome. J Clin Invest 54:486, 1974
37. Gealy WJ, Dwyer JM, Harley JB: Allelic exclusion of glucose-6-phosphate dehydrogenase in platelets and T lymphocytes from a Wiskott-Aldrich carrier. Lancet 1:63, 1980
38. Prchal JT, Carroll AJ, Prchal JF, Crist WM, Skalka HW, Gealy WJ, Harley J, Malluh A: Wiskott-Aldrich syndrome: Cellular impairments and their implication for carrier detection. Blood 56:1048, 1980
39. Fearon ER, Kohn DB, Winkelstein JA, Vogelstein B, Blaese RM: Carrier detection in the Wiskott Aldrich Syndrome. Blood 72:1735, 1988
40. Greer WL, Kwong PC, Peacocke M, Ip P, Rubin LA, Siminovitch KA: X-chromosome inactivation in the Wiskott-Aldrich Syndrome: A marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics 4:60, 1989
41. Mantuano E, Candotti F, Giliani S, Parolini O, Lusardi M, Zucchi M, Lanfranchi A, Porta F, Airo P, Albertini A, Ugazio AG, Notarangelo LD: Analysis of X-chromosome inactivation in bone marrow percursors from carriers of Wiskott-Aldrich syndrome and X-linked severe combined immunodeficiency: Evidence that the Wiskott-Aldrich gene is expressed prior to granulocyte-macrophage colony-forming unit. Immunodeficiency 4:271, 1993
42. Wengler G, Gorlin JB, Williamson JM, Rosen FS, Bing DH: Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 85:2471, 1995
43. Lyon MF: Mechanisms and evolutionary origins of variable X-chromosome activity in mammals. Proc R Soc London Ser B 187:243, 1974
44. Conley ME: Molecular approaches to analysis of X-linked immunodeficiencies. Annu Rev Immunol 10:215, 1992
45. Remold-O'Donnell E, Rosen FS: Sialophorin (CD43) and the Wiskott-Aldrich syndrome. Immunodef Rev 2:151, 1990
46. Winkelstein JA, Fearon E: Carrier detection of the X-linked primary immunodeficiency diseases using X-chromosome inactivation analysis. J Clin Lab Immunol 85:1090, 1990
47. Puck JM, Siminovitch KA, Poncz M, Greenberg CR, Rottem M, Conley ME: Atypical presentation of Wiskott-Aldrich syndrome: Diagnosis in two unrelated males based on studies of maternal T cell X-chromosome inactivation. Blood 75:2369, 1990
48. Kwan S-P, Sandkuyl LA, Blaese RM, Kunkel LM, Bruns G, Parmley R, Skarshaug S, Page DC, Ott J, Rosen FS: Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers. Genomics 3:39, 1988
49. Greer WL, Mahtani M, Kwong PC, Rubin LA, Peacocke M, Willard HF, Siminovitch KA: Linkage studies of the Wiskott-Aldrich syndrome: Polymorphisms at TIMP and the X-chromosome centromere are informative markers for genetic prediction. Hum Genet 83:227, 1989
50. Kwan S-P, Lehner T, Hagemann T, Lu B, Blaese M, Ochs H, Wedgwood R, Ott J, Craig IW, Rosen FS: Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-Xp11.3. Genomics 10:29, 1991
51. de Saint-Basile G, Arveiler B, Fraser NJ, Boyd Y, Craig IW, Griscelli G, Fischer A: Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome. Lancet 2:1319, 1989
52. Greer WL, Peacocke M, Siminovitch KA: The Wiskott-Aldrich syndrome: refinement of the localization on Xp and identification of another closely linked marker locus, OATL1. Hum Genet 88:453, 1992
53. Kwan S-P, Lehner T, Lu B, Raghu G, Blaese RM, Sandkuyl LA, Ott J, Fraser N, Boyd Y, Craig IW, Fischer S, Rosen FS: Linkage of DXS255 to the Wiskott-Aldrich syndrome gene. Cytogenet Cell Genet 51:1027, 1989 (abstr)
54. Kwan S-P, Hagemann TL, Blaese RM, Rosen FS: A high resolution map of genes, microsatellite markers and new dinucleotide repeats from UBE1 to the GATA locus in the region Xp11.23. Genomics 29:247, 1995
55. Kwan S-P, Hagemann TL, Radtke BE, Blaese RM, Rosen FS: Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940 adjacent to the disease gene. Proc Natl Acad Sci USA 92:4706, 1995
56. Kwan S-P, Hagemann TL, Blaese RM, Knutsen A, Rosen FS: Scanning of the Wiskott-Aldrich syndrome (WAS) gene: Identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. Hum Molec Genet 4:1995, 1995
57. Kolluri R, Shehabeldin A, Peacocke M, Lamhonwah AM, Teichert-Kuliszewska K, Weissman SM, Siminovitch KA: Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum Mol Genet 4:1119, 1995
58. Derry JMJ, Kerns JA, Weinberg KI, Ochs HD, Volpini V, Estivill X, Walker AP, Francke U: WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum Molec Genet 4:1127, 1995
59. Zhu Q, Zhang M, Blaese RM, Derry JMJ, Junker A, Francke U, Chen S-H, Ochs HD: The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood 86:3797, 1995
60. Schaar FE: Familial idiopathic thrombocytopenic purpura. J Pediatr 62:546, 1963
61. Canales ML, Mauer AM: Sex-linked hereditary thrombocytopenia as a variant of Wiskott-Aldrich syndrome. N Engl J Med 277:899, 1967
62. Cohn J, Hauge M, Andersen V, Henningsen K, Nielsen LS, Thomsen M, Iversen T: Sex-linked hereditary thrombocytopenia with immunological defects. Hum Hered 25:309, 1975
63. Andersen V, Thomsen M, Cohn J: Immune deficiency in sex-linked hereditary thrombocytopenia. Acta Path Microbiol Scand 83:177, 1975
64. Donner M, Schwartz M, Carlsson KU, Holmberg L: Hereditary X-linked thrombocytopenia maps to the same chromosomal region as the Wiskott-Aldrich syndrome. Blood 72:1849, 1988
65. de Saint-Basile G, Schlegel N, Caniglia M, LeDeist F, Kaplan C, Lecompte T, Piller F, Fischer A, Oriscelli C: X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers. Ann Hematol 63:107, 1991
66. Gerber H-P, Seipel K, Georgiev O, Hofferer M, Hug M, Rusconi S, Schaffner W: Transcriptional activation modulated by homopolymeric glutamine and praline stretches. Science 263:808, 1994
67. Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber SL: Structural basis for the binding of proline-rich polypeptides to SH3 domains. Cell 76:933, 1994
68. Pawson T: Protein modules and signalling networks. Nature 373:573, 1995
69. Bretscher A: Microfilaments and membranes. Curr Opin Cell Biol 5:653, 1993
70. Scott BT, Simmerman HKB, Cotlins JH, Nadal-Ginard B, Jones LR: Complete amino acid sequence of canine cardiac calsequestrin deduced by cDNA cloning. J Biol Chem 263:8958, 1988
71. Palek J and Jarolim P: Hereditary spherocytosis, elliptocytosis and related disorders, in BeutlerE, Lichtman MA, Coller BS, Kipps TJ (eds): Williams Hematology. New York, NY, McGraw-Hill, 1993, p 536
72. Campbell KP, Kahl SD: Association of dystrophin and an integral membrane glycoprotein. Nature 338:259, 1989
73. Ervasti JN, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP: Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315, 1990
74. Turner PR, Westwood T, Regen CM, Steinhardt RA: Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 335:735, 1988
75. Pidard D, Didry D, Le Deist F, Durandy A, Griscelli C, Bellucci S, Nurden AT: Analysis of the membrane glycoproteins of platelets in the Wiskott-Aldrich syndrome. Br J Haematol 69:529, 1988
76. Parkman R, Remold-O'Donnell E, Kenney DM, Perrine S, Rosen FS: Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome. Lancet 2:1387, 1981
77. Remold-O'Donnell E, Kenney DM, Parkman R, Cairns L, Savage B, Rosen FS: Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med 159:1705, 1984
78. Remold-O'Donnell E, Zimmerman C, Kenney D, Rosen FS: Expression of blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome. Blood 70:104, 1987
79. Piller F, Piller V, Fox RI, Fukuda M: Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem 263:15146, 1988
80. Piller F, Le Deist F, Weinberg KI, Parkman R, Fukuda M: Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. J Exp Med 173:1501, 1991
81. Higgins EA, Siminovitch KA, Zhuang DL, Brockhausen I, Dennis JW: Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J Biol Chem 266:6280, 1991
82. Peacocke M, Siminovitch KA: Wiskott-Aldrich syndome: New molecular and biochemical insights. J Am Acad Dermatol 27:507, 1992
83. Simon HU, Higgins EA, Demetriou M, Datti A, Siminovitch KA, Dennis JW: Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS). Clin Exp Immunol 91:43, 1993
84. Simon HU, Mills GB, Hashimoto S, Siminovitch KA: Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. J Clin Invest 90:1396, 1992
85. Henriquez NV, Rijkers GT, Zegers BJM: Antigen receptor-mediated transmembrane signaling in Wiskott-Aldrich syndrome. J Immunol 153:395, 1994
86. Ardman B, Sikorski MA, Settles M, Staunton DE: Human immunodeficiency virus type I-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes. J Exp Med 172:1151, 1990
87. LeFebvre JC, Giordanengo V, Limouse M, Doglio A, Cucchiarini M, Monpoux F, Mariani R, Peyron JF: Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. J Exp Med 180:1609, 1994
88. Remold-O'Donnell E, Rosen FS: Proteolytic fragmentation of sialophorin (CD43). Localization of the activation-inducing site and examination of the role of sialic acid. J Immunol 145:3372, 1990
89. Reisinger D, Parkman R: Molecular heterogeneity of a lymphocyte glycoprotein in immunodeficient patients. J Clin Invest 79:595, 1987
90. Carraway KL, Hull SR: Cell surface mucin-type glycoproteins and mucin-like domains. Glycobiology 1:131, 1991
91. Shogren R, Gerken TA, Jentoft N: Role of glycosylation on the conformation and chain dimensions of O-linked glycoproteins: Light-scattering studies of ovine submaxillary mucin. Biochemistry 28:5525, 1989
92. Cyster JG, Shotton DM, Williams AF: The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J 10:893, 1991
93. Barclay AN, Birkeland ML, Brown MH, Beyers AD, Davis SJ, Somoza C, Williams AF: The Leucocyte Antigen Facts Book. San Diego, CA, Academic, 1993
94. Ardman B, Sikorski MA, and Staunton DE: CD43 interferes with T-lymphocyte adhesion. Proc Natl Acad Sci USA 89:5001, 1992
95. Manjunath N, Johnson RS, Staunton DE, Pasqualini R, Ardman B: Targeted disruption of CD43 gene enhances T lymphocyte adhesion. J Immunol 151:1528, 1993
96. Sperling AI, Green JM, Mosley RL, Smith PL, DiPaolo RJ, Klein JR, Bluestone JA. Thompson CB: CD43 is a murine T cell costimulatory receptor that functions independently of CD28. J Exp Med 182:139, 1995
97. Kenney D, Cairns L, Remold-O'Donnell E, Peterson J, Rosen FS, Parkman R: Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood 68:1329, 1986
98. Yonemura S, Nagafuchi A, Sato N, and Tsukita S: Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons. J Cell Biol 120:437, 1993
99. Erlandseri SL, Hasslen SR, Nelson RD: Detection and spatial distribution of the β2 integrin (Mac-1) and L-selectin (LECAM-1) adherence receptors on human neutrophils by high-resolution field emission SEM. J Histochem Cytochem 41:327, 1993
100. Moore KL, Patel KD, Bruehl RE, Fugang L, Johnson DA, Lichenstein HS, Cummings RD, Bainton DF, McEver RP: P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol 128:661, 1995
101. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC: α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413, 1995
102. Arpin M, Algrain M, Louvard D: Membrane-actin microfilament connections: An increasing diversity of players related to band 4.1. Curr Opin Cell Biol 6:136, 1994
103. Gary R, Bretscher A: Heterotypic and homotypic associations between ezrin and moiesin, two putative membrane-cytoskeletal linking proteins. Proc Natl Acad Sci USA 90:10846, 1993
104. Martin M, Andreoli C, Sahuquet A, Montcourrier P, Algrain M, Mangeat P: Ezrin NH2-terminal domain inhibits the cell extension activity of the COOH-terminal domain. J Cell Biol 128:1081, 1995
105. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S: Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 125:1371, 1994
106. 2+-dependent protease during platelet aggregation. J Biol Chem 260:1060, 1985
107. Murachi T: Intracellular regulatory system involving calpain and calpastatin. Biochem Intern 18:263, 1989
108. Schmaier AH, Bradford HN, Lundberg D, Farber A, Colman RW: Membrane expression of platelet calpain. Blood 75:1273, 1990
109. Croall DE: Proteolytic modification of calcium-dependent protease 1 in erythrocytes treated with ionomycin and calcium. Biochemistry 28:6882, 1989
110. Fox JEB, Austin CD, Reynolds CC, Steffen PK: Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 266:13289, 1991
111. 2+-dependent neutral protease) in the destructive thrombocytopenia of the Wiskott-Aldrich syndrome. Br J Hematol 87:773, 1994
112. 2+-activated neutral proteinase (calpain). Blood 74:715, 1989
113. Kelton JG, Warkentin TE, Hayward CPM, Murphy WG, Moore JC: Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood 80:2246, 1992
114. Remold-O'Donnell E, Van Brooklyn J, Kenney DM: Effect of platelet calpain on normal T-lymphocyte CD43: Hypothesis of events in the Wiskott-Aldrich syndrome. Blood 79:1754, 1992
115. Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold-O'Donnell E: T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol 151:4383, 1993
116. Molina IJ, Kenney DM, Rosen FS, Remold-O'Donnell E: T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J Exp Med 176:867, 1992
117. Boyles J, Fox JEB, Phillips DR, Stenberg PE: Organization of the cytoskeleton in resting, discoid platelets: Preservation of actin filaments by a modified fixation that prevents osmium damage. J Cell Biol 101:1463, 1985
118. Zucker-Franklin D, Melton JW III, Quagliata F: Ultrastructural, immunologic, and functional studies on Sézary cells: A neoplastic variant of thymus-derived (T) lymphocytes. Proc Natl Acad Sci USA 71:1877, 1974
119. Zucker-Franklin, D, Liebes LF, Silber R: Differences in the behavior of the membrane and membrane-associated filamentous structures in normal and chronic lymphocytic leukemia (CLL) lymphocytes. J Immunol 122:97, 1979